Basics Stoke Therapeutics, Inc. IPO Date: June 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $1.76B Activated in VL: True Average Daily Range Avg Daily Range: $0.65 | 3.30% Avg Daily Range (30 D): $0.88 | 3.20% Avg Daily Range (90 D): $0.73 | 2.98% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .78M Avg Daily Volume (90 D): .87M Trade Size Avg Trade Size (Sh.): 75 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 1,305 Avg Inst. Trade: $1.99M Avg Inst. Trade (30 D): $3.38M Avg Inst. Trade (90 D): $2.97M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.71M Avg Closing Trade (30 D): $3.6M Avg Closing Trade (90 D): $3.39M Avg Closing Volume: 96.07K     News Jun 28, 2024 @ 4:01 PM A Closer Look at 5 Analyst Recommendations For Sto... Source: Benzinga Insights May 6, 2024 @ 3:01 PM Analyst Expectations For Stoke Therapeutics's Futu... Source: Benzinga Insights May 6, 2024 @ 12:05 PM Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, T... Source: Zacks Equity Research Apr 29, 2024 @ 2:00 PM Earnings Preview: Axsome Therapeutics (AXSM) Q1 Ea... Source: Zacks Equity Research Apr 25, 2024 @ 2:01 PM Earnings Preview: Stoke Therapeutics, Inc. (STOK) ... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $.71 $-.65 $-.4 Diluted EPS $.68 $-.65 $-.4 Revenue $ 205.63M $ 10.63M $ 13.82M Gross Profit $ $ $ Net Income / Loss $ 40.57M $ -38.35M $ -23.48M Operating Income / Loss $ 27.2M $ -43.09M $ -27.3M Cost of Revenue $ $ $ Net Cash Flow $ -66.47M $ -18.15M $ -173.35M PE Ratio 45.46     Splits Jun 06, 2019:   10:99